XML 24 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2024
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

10. Stock-Based Compensation

Stock Incentive Plan

The Company maintains a stock-based compensation plan, the 2011 Incentive Compensation Plan, as amended (the “2011 Plan”), to attract, motivate, retain and reward employees, directors and consultants by providing its Board or a committee of the Board the discretion to award equity incentives to these persons.

Stock Options

A summary of stock option activity for the three months ended March 31, 2024 is as follows:

 

 

 

Number
Outstanding

 

 

Weighted Average Exercise
Price per Share

 

 

Weighted Average
Remaining
Contractual Term
(Years)

 

 

Aggregate
Intrinsic
Value

 

Balance as of January 1, 2024

 

 

494,960

 

 

$

4.99

 

 

 

2.23

 

 

$

1,725,985

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled or Expired

 

 

(7,500

)

 

 

8.97

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 31, 2024

 

 

487,460

 

 

$

4.93

 

 

 

2.01

 

 

$

1,583,118

 

Vested or expected to vest as of March 31, 2024

 

 

487,460

 

 

$

4.93

 

 

 

2.01

 

 

$

1,583,118

 

Exercisable as of March 31, 2024

 

 

487,460

 

 

$

4.93

 

 

 

2.01

 

 

$

1,583,118

 

 

The aggregate intrinsic value in the table above represents the difference between the fair value of the Company’s common stock as of March 31, 2024 and the exercise price of in-the-money stock options multiplied by the number of such stock options.

The following table summarizes information about stock options outstanding as of March 31, 2024:

 

 

 

Stock Options Outstanding

 

 

Stock Options Exercisable

 

Range of Exercise Prices

 

Number
Outstanding

 

 

Weighted
Average
Remaining
Contractual Life
(Years)

 

 

Weighted
Average
Exercise
Price

 

 

Number
Exercisable

 

 

Weighted
Average
Exercise
Price

 

$4.36 - $7.20

 

 

446,460

 

 

 

2.17

 

 

$

4.37

 

 

 

446,460

 

 

$

4.37

 

$10.93 - $16.40

 

 

41,000

 

 

 

0.25

 

 

 

10.93

 

 

 

41,000

 

 

 

10.93

 

$4.36 - $16.40

 

 

487,460

 

 

 

2.01

 

 

$

4.93

 

 

 

487,460

 

 

$

4.93

 

 

As of March 31, 2024, there was no unrecognized stock-based compensation expense related to stock options.

Restricted Stock Units

The following is a summary of RSU activity for the three months ended March 31, 2024:

 

 

 

Number
Outstanding

 

 

Weighted Average
Fair Value

 

Unvested as of January 1, 2024

 

 

730,062

 

 

$

11.17

 

Granted

 

 

127,919

 

 

 

8.63

 

Vested

 

 

(106,761

)

 

 

10.16

 

Forfeited

 

 

 

 

 

 

Unvested as of March 31, 2024

 

 

751,220

 

 

$

10.88

 

RSUs vested but not released

 

 

65,568

 

 

$

10.72

 

 

 

The fair value of the Company’s RSUs is calculated based upon the fair market value of the Company’s common stock at the date of grant. As of March 31, 2024, there was $7.0 million of unrecognized compensation expense related to unvested RSUs granted, which is expected to be recognized over a weighted average period of 2.3 years. No tax benefit was realized from RSUs for the three months ended March 31, 2024.

Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense related to stock options and RSUs included in the condensed consolidated statements of comprehensive income (loss) for the three months ended March 31, 2024 and 2023 (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2024

 

 

2023

 

Cost of revenue

 

$

47

 

 

$

45

 

Research and development

 

 

182

 

 

 

202

 

Selling and marketing

 

 

264

 

 

 

293

 

General and administrative

 

 

526

 

 

 

450

 

Total

 

$

1,019

 

 

$

990

 

 

Restricted Stock Unit Net Share Settlements

During the three months ended March 31, 2024 and 2023, the Company repurchased 32,608 and 24,812 shares, respectively, of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of RSUs issued to employees.